<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01957670</url>
  </required_header>
  <id_info>
    <org_study_id>LM001</org_study_id>
    <nct_id>NCT01957670</nct_id>
  </id_info>
  <brief_title>Pilot Study to Clinical Evaluate Device Prototypes in Dry Eye Patients</brief_title>
  <official_title>Pilot, Open-label, Single-Arm Study Designed to Clinically Evaluate Various Lacrima Medical Device Prototypes in Adult Patients With Dry Eye Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lacrima Medical LTD</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lacrima Medical LTD</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will assess the safety, tolerability and feasibility of Lacrima investigational
      medical device to treat dry eye patients
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Sponsor decision due to change the clinical indication to Chronic Insomnia
  </why_stopped>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">April 2016</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lower Tear Meniscus Height using Optical Coherence Tomography</measure>
    <time_frame>up to 8 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Scale score</measure>
    <time_frame>up to 8 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Dry Eye Syndrome</condition>
  <arm_group>
    <arm_group_label>Treatment with Lacrima medical device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lacrima medical Prototypes</intervention_name>
    <arm_group_label>Treatment with Lacrima medical device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Main Inclusion Criteria:

          1. Male or female, 18 years of age and over at screening

          2. Diagnosis of mild to moderate Dry Eye, as defined by:

               1. Positive corneal fluorescein staining , defined as a corneal punctate fluorescein
                  staining score of ≥3 in either eye by the National Eye Institute evaluation scale
                  summed over 5 areas, each with a 0-3 scoring scale; AND

               2. Schirmer Test score (with anesthesia, 5 minutes &lt; 5 mm either eye) ; AND

               3. OSDI score of ≥12 and OSDI score of &lt;33

        Main Exclusion Criteria:

          1. Persistent intraocular inflammation or infection including conjunctivitis at the time
             of the study or 2 weeks prior to study start.

          2. Any concomitant active or history of eye disease including, but not limited to lid
             abnormalities, nasolacrimal obstruction, active ulcer, glaucoma or ocular herpes
             simplex virus infection

          3. Patients currently using topical steroidal or anti-inflammatory eye drops for 1 month
             prior to screening

          4. Receipt of any type of topical artificial eye drops within 3 days prior to screening

          5. Receipt of topical cyclosporine eye drops within 3 months prior to screening
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tel Aviv Sourasky Medical Center, Israel</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 30, 2013</study_first_submitted>
  <study_first_submitted_qc>September 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2013</study_first_posted>
  <last_update_submitted>March 6, 2016</last_update_submitted>
  <last_update_submitted_qc>March 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Keratoconjunctivitis Sicca</keyword>
  <keyword>Dry Eye Syndromes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
    <mesh_term>Dry Eye Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

